STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATTO
  4. [144] Attovia Therapeutics, Inc. SEC Filing

Goldman to sell $2.2M in Attovia Therapeutics (ATTO) stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Attovia Therapeutics, Inc. (ATTO) is the issuer in a Notice of Proposed Sale of Securities on Form 144 filed in connection with planned sales of its common stock by Goldman Sachs Group Inc., identified as a former 10% owner. The notice covers up to 105,807 shares of Attovia common stock. The shares to be sold were acquired through securities borrowing by Goldman Sachs & Co. LLC, which is acting as a market maker in the ordinary course of business, and trades may occur on CBOE, IEX, MEMX and Nasdaq. The Form 144 is a resale notice for the selling party; Attovia does not sell shares or receive proceeds in this transaction.

Positive

  • None.

Negative

  • None.
Shares covered by notice 105,807 shares of common stock Maximum number of Attovia Therapeutics, Inc. shares listed for potential sale under Rule 144
Aggregate market value $2,221,947.00 Aggregate market value associated with the 105,807 shares of Attovia common stock
Shares outstanding 43,029,017 shares Attovia Therapeutics, Inc. common shares outstanding reported in the Form 144
Proposed sale date 08/05/2026 Date associated with the proposed sale of common stock and holding-period information
Shares to be sold entry 105,807 shares Number of shares shown in the Securities To Be Sold section for common stock
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
securities borrowing financial
"Shares sold were acquired through securities borrowing by Goldman Sachs & Co. LLC"
market maker financial
"Goldman Sachs & Co. LLC acting as a market maker in the ordinary course of business."
A market maker is a firm or individual that stands ready to buy and sell a particular stock or other security throughout the trading day, posting prices at which it will transact so buyers and sellers can trade quickly. Think of it as a shopkeeper who keeps inventory and posts prices to ensure someone can always buy or sell; this reduces delays, narrows price swings, and helps investors execute trades at fairer, more predictable prices.
Former 10% Owner regulatory
"Former 10% Owner 144: Securities Information"
Form 144 regulatory
"144: Issuer Information Name of Issuer | Attovia Therapeutics, Inc."
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does the Form 144 filing mean for Attovia Therapeutics, Inc. (ATTO)?
The filing reports that a party associated with Goldman Sachs Group Inc. intends to sell up to 105,807 shares of Attovia common stock under Rule 144. This is a resale by that party; Attovia is not issuing new shares or receiving proceeds.

How many ATTO shares are covered by this Goldman Sachs Form 144?
The notice covers up to 105,807 shares of Attovia Therapeutics, Inc. common stock. These shares were acquired through securities borrowing by Goldman Sachs & Co. LLC acting as a market maker in the ordinary course of business.

What is the aggregate market value of ATTO shares in this Form 144?
The Form 144 lists an aggregate market value of approximately $2,221,947.00 for the 105,807 shares of Attovia common stock covered by the notice, based on market prices at the time indicated in the form.

How many Attovia (ATTO) shares are outstanding according to this filing?
The filing reports 43,029,017 shares of Attovia Therapeutics, Inc. common stock outstanding. This is a context figure for Rule 144 and is not the number of shares being sold; the notice covers 105,807 shares for potential resale.

Where may the ATTO shares in this Form 144 be traded?
The remarks state that trades related to this notice may occur on CBOE, IEX, MEMX and Nasdaq. Goldman Sachs & Co. LLC is acting as a market maker in the ordinary course of business for these transactions.

Does Attovia Therapeutics (ATTO) receive any proceeds from this Form 144 sale?
No. The Form 144 covers a resale of Attovia common stock by a party associated with Goldman Sachs Group Inc.. The company is not selling the shares, so it does not receive proceeds from these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR